Caxton Associates (UK)
ACA icon

Caxton Associates (UK)’s Arcosa ACA Stock Holding History

Caxton Associates (UK)’s Portfolio ACA Stock Details ACA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$67.8M Buy
+464,102
New +$67.4M 1.4% 18

Other funds holding ACA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return
Soros Fund Management
Soros Fund Management New York $8.51B AUM 25.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Caxton Associates (UK)'s ACA Position: Q3 2026 in Review

Caxton Associates (UK) opened a new position in Arcosa (ACA) in Q3 2026: 464,102 shares worth $67.8M. The stake represents 1.4% of the portfolio and ranks #18 among its holdings.

334 funds tracked by Wall St. Rank hold ACA as of Q3 2026.

  • Caxton Associates (UK) held 464,102 shares of Arcosa worth $67.8M as of Q3 2026.
  • Arcosa was a new Caxton Associates (UK) position in Q3 2026.
  • Arcosa made up 1.4% of Caxton Associates (UK)'s portfolio in Q3 2026, its #18 holding.
  • 334 funds tracked by Wall St. Rank held Arcosa as of Q3 2026.

Based on Caxton Associates (UK)'s 13F filing for Q3 2026, filed 13 Nov 2026.